Identification and Treatment of Pathophysiological Comorbidities of Autism Spectrum Disorder to Achieve Optimal Outcomes.
about
Folinic acid improves verbal communication in children with autism and language impairment: a randomized double-blind placebo-controlled trial.In Search of Autism's RootsMetabolic Dysfunction Underlying Autism Spectrum Disorder and Potential Treatment Approaches.Folate metabolism abnormalities in autism: potential biomarkers.The role of probiotics in children with autism spectrum disorder: A prospective, open-label study.Ketogenic diet and childhood neurological disorders other than epilepsy: an overview.Vitamin D and autism, what's new?Neurobiological bases of autism-epilepsy comorbidity: a focus on excitation/inhibition imbalance.Evidence of Mitochondrial Dysfunction in Autism: Biochemical Links, Genetic-Based Associations, and Non-Energy-Related Mechanisms.Mitochondrial dysfunction in the gastrointestinal mucosa of children with autism: A blinded case-control study.Bioenergetic variation is related to autism symptomatology.Modulation of Immunological Pathways in Autistic and Neurotypical Lymphoblastoid Cell Lines by the Enteric Microbiome Metabolite Propionic Acid.Maternal breastfeeding and autism spectrum disorder in children: A systematic review and meta-analysis.Butyrate enhances mitochondrial function during oxidative stress in cell lines from boys with autism.What Have Proteomic Studies Taught Us About Novel Drug Targets in Autism?Clinical and Molecular Characteristics of Mitochondrial Dysfunction in Autism Spectrum DisorderMelatonin and Comorbidities in Children with Autism Spectrum Disorder
P2860
Q34542848-9F14DAC5-1ED3-484C-A176-E0918959DE5AQ36149932-63D3ABA5-5BC2-4B98-98DF-74FD45A62178Q37653680-3D1D047B-9E7E-4A1B-807D-BF05679E3EBAQ38645047-1FE0D316-5F95-48B9-B47B-9899029DD931Q38689399-92465B34-862D-4910-B8AD-370F9A194E72Q39007510-73971648-B31C-4A12-B6DF-3E6A1F21A5BDQ39144032-658BC408-DB38-4CEF-9B4B-EE2F204E0243Q39269008-EC6E73EC-D8EF-4736-ABAE-E975EE86C82DQ39384617-8AC06AA8-8033-4A9B-9628-3EBBB2808CC3Q42701655-F4C6D89A-177F-4DBF-A1F3-51F4740D0C10Q44602403-A6AD1201-96D8-4CC9-8EFF-6C84EC5F1FE6Q47194149-1FB28D04-9A5A-4D43-8FEC-8A5A7C417A81Q47594215-4CB28E36-A23B-4678-8462-081A982DCBB3Q47640046-99B32E89-74A6-4499-B1C1-2727CC346612Q47812079-066BF7CD-97C5-45BC-B62B-E2559CD6F7A4Q57922552-FFC8B32C-5E2B-49C3-A82D-73556B21977FQ58793019-D81CB457-6FB9-4199-8488-12F6143ABA2F
P2860
Identification and Treatment of Pathophysiological Comorbidities of Autism Spectrum Disorder to Achieve Optimal Outcomes.
description
2016 nî lūn-bûn
@nan
2016 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
name
Identification and Treatment o ...... er to Achieve Optimal Outcomes
@nl
Identification and Treatment o ...... r to Achieve Optimal Outcomes.
@ast
Identification and Treatment o ...... r to Achieve Optimal Outcomes.
@en
type
label
Identification and Treatment o ...... er to Achieve Optimal Outcomes
@nl
Identification and Treatment o ...... r to Achieve Optimal Outcomes.
@ast
Identification and Treatment o ...... r to Achieve Optimal Outcomes.
@en
prefLabel
Identification and Treatment o ...... er to Achieve Optimal Outcomes
@nl
Identification and Treatment o ...... r to Achieve Optimal Outcomes.
@ast
Identification and Treatment o ...... r to Achieve Optimal Outcomes.
@en
P2860
P921
P3181
P356
P1476
Identification and Treatment o ...... r to Achieve Optimal Outcomes.
@en
P2093
Daniel A Rossignol
Richard E Frye
P2860
P3181
P356
10.4137/CMPED.S38337
P407
P577
2016-06-15T00:00:00Z